Kumar Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.11 M
as on 04-01-2025
- Paid Up Capital ₹ 0.11 M
as on 04-01-2025
- Company Age 1 Year 9 Months
- Last Filing with ROC 31 Mar 2024
About Kumar Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.11 M and a paid-up capital of Rs 0.11 M, as per Ministry of Corporate Affairs (MCA) records.
Bherulal Chopra, Mohanlal Chopra, Amitkumar Chopra, and Two other members serve as directors at the Company.
- CIN/LLPIN
U86100GJ2023PTC139923
- Company No.
139923
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Apr 2023
- Date of AGM
25 Dec 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kumar Life Sciences?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Chopra  | Director | 09-Apr-2023 | Current |
| Shreyans Chopra | Director | 09-Apr-2023 | Current |
| Bherulal Chopra | Director | 09-Apr-2023 | Current |
| Mohanlal Chopra | Director | 09-Apr-2023 | Current |
| Amitkumar Chopra | Director | 09-Apr-2023 | Current |
Financial Performance of Kumar Life Sciences.
Enhance accessibility to Kumar Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Kumar Life Sciences?
Unlock access to Kumar Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Aico Foods LimitedActive 29 years 1 monthBherulal Chopra, Mohanlal Chopra and 3 more are mutual person
- Aico Laboratories India LimitedActive 32 years 3 months
Bherulal Chopra and Mohanlal Chopra are mutual person
- Kumar Techno Private LimitedActive 14 years 11 months
Bherulal Chopra, Mohanlal Chopra and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kumar Life Sciences?
Unlock and access historical data on people associated with Kumar Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kumar Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kumar Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.